February 20 @ 8:00 am - 11:00 am AEDT
mRNA LECTURE SERIES 2:
Based on the demand and success of the first lecture series, mRNA Victoria and BioMelbourne Network, are pleased to host a second series of four lectures beginning in November 2023 for the Victorian RNA community.
These lectures present an opportunity for global leading specialists in the RNA field to share their knowledge with the local RNA community. The accompanying networking sessions are an opportunity to foster connections between researchers, industry and government to build a connected and collaborative ecosystem in Victoria.
Explore mRNA Lecture Series 2 and 1
Series 2 comprises four lectures:
Lecture One: The RNA Platform: The Breadth of Possibility Beyond mRNA | Friday 10 November 2023, 8:00am – 11:00am
Lecture Two: mRNA Clinical Trials: Enhancing Research-Clinician Collaboration to Accelerate Patient Outcomes | Tuesday 20 February 2024, 8:00am – 11:00am
Lecture Three: Details tbc | Friday 15 March 2024, 8:00am – 11:00am
Lecture Four: Details tbc | Tuesday 28 May 2024, 8:00am – 11:00am
SERIES 2 | LECTURE TWO | mRNA Clinical Trials: Enhancing Research-Clinician Collaboration to Accelerate Patient Outcomes
The agility of the mRNA platform provides new opportunities for innovation in the delivery of clinical trials that could accelerate and improve the drug development process. This lecture will explore the opportunities of mRNA Clinical trials for researchers, clinicians and the broader sector and speakers will share their experiences from conducting their own mRNA clinical trials.
Who should attend?
The intended audience is those that have an interest in developing an mRNA candidate to take to clinical trials, researchers who have non-mRNA candidates who are exploring an accelerated option using the mRNA platform, and industry professionals, students and academics who are interested to learn more about the workforce opportunities to support the mRNA industry in the future.
Our speakers will explore the following topics:
Personalised cancer vaccine trials: challenges and opportunities – Professor Riccardo Dolcetti, Head, Clinical and Translational Immunotherapy, Peter MacCallum Cancer Centre
mRNA an opportunity to accelerate medicine development and increase your chance of success – Dr Iris Depaz, Country Medical Lead & Head of Medical Vaccines, Sanofi ANZ
The emerging workforce for producing doses for clinical trials – broader opportunities for the Australian ecosystem – Associate Professor Jennifer Short, Director, Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training
Facilitated by – Dr Kylie Quinn, Vice-Chancellor’s Research Fellow, School of Health and Biomedical Sciences, RMIT University
Lecture Two Details:
Date: Tuesday 20 February 2024
Time (AEDT):
7:45am: Guest arrival, registration
8:00am: Networking breakfast (executive lounge)
9:00am: Welcome and opening remarks
9:15am: Presentations and Q&A
10:30am: Networking, tea and coffee (executive lounge)
11:00am: Close
Format: In-person only
Venue: Treasury Theatre, Lower Plaza, 1 Macarthur Street, East Melbourne
REGISTRATION (IN PERSON ONLY)
BioMelbourne Network Members: $0
BioMelbourne Network Non Members: $85
CANCELLATION POLICY
Full refund given up to 7 days prior to the event.
No refunds within 7 days of the event.
About mRNA Victoria
mRNA Victoria is responsible for leading the Victorian Government’s commitment to establish a world-class mRNA and RNA industry in Victoria, by supporting supply chain, research and development for pre and clinical research, commercialisation and manufacturing investments.Its role is to identify key capabilities, gaps, opportunities and lead the Victorian Government’s engagement, investment and partnerships with domestic and international companies, researchers and stakeholders to build RNA capability.
This lecture series is delivered in partnership with mRNA Victoria and the State Government of Victoria